Intact Genomics Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 9

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1000K

  • Investors
  • 5

Intact Genomics General Information

Description

Operator of a biotech research and development company intended to offer life science products and services. The company provides large insert DNA cloning, manipulation, and bacterial artificial chromosome library-related services and products, enabling scientists to explore the genome structure and function of microorganisms, plants, and animal species.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 11840 Westline Industrial Drive
  • Suite 120
  • Saint Louis, MO 63146
  • United States
+1 (314) 000-0000

Intact Genomics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intact Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Grant 01-Jul-2022 $1000K 000 Completed
13. Grant 15-Jan-2019 000 000 Completed
12. Later Stage VC 0000 Upcoming Generating Revenue
11. Seed Round 000 000 Completed Generating Revenue
10. Grant 01-Jul-2022 00.000 Completed Generating Revenue
9. Debt - PPP 03-May-2020 Completed Generating Revenue
8. Grant 01-Jan-2020 000 Completed Generating Revenue
7. Grant 01-Jan-2019 00000 Completed Generating Revenue
6. Grant 01-Jun-2018 $1.5M Completed Generating Revenue
5. Grant 01-Jan-2018 $229K Completed Generating Revenue
To view Intact Genomics’s complete valuation and funding history, request access »

Intact Genomics Patents

Intact Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190264216-A1 Fungal artificial chromosomes, compositions, methods and uses therefor Pending 25-Jan-2016 000000000 0
US-10337019-B2 Fungal artificial chromosomes, compositions, methods and uses therefor Active 25-Jan-2016 000000000
US-20170211077-A1 Fungal artificial chromosomes, compositions, methods and uses therfor Active 25-Jan-2016 C12N15/80

Intact Genomics Executive Team (2)

Name Title Board Seat Contact Info
Chengcang Wu Ph.D Co-Founder & Chief Executive Officer
Rosa Ye Co-Founder & Chief Operating Officer
To view Intact Genomics’s complete executive team members history, request access »

Intact Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intact Genomics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institute Of Allergy and Infectious Diseases Government 000 0000 000000 0
United States Centers for Disease Control and Prevention Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Accelerate St. Louis Accelerator/Incubator 000 0000 000000 0
To view Intact Genomics’s complete investors history, request access »